Health Care · Health Care Services

Chemed Corp CHE

$509.34-1.79 (-0.35%)delayed quote · as of 2026-07-28 06:38 UTC

Open CHE in the workspaceCharts, statements, and the evidence behind every figure — free to start.

Market cap

$6.8B

Previous close

$511.13

Volume

125K

52-week range

$365.21 – $517.74

Verdictconfidence 88% · high

Strong across every dimension we score.

5 of 5 dimensions score well.

Value804/5 checks

Growth1005/5 checks

Quality753/4 checks

Health1003/3 checks

Momentum804/5 checks

Fair-value estimate $1,010.76 per share (2-stage FCF · individual beta · 10Y Rf 4.7%) — the price sits 50% below it.

Every check behind these scores — with its numbers, source, and evidence link — is in the workspace. Free account required.

Key ratioslatest filing FY 2025

Value

P/E TTM

27.8

P/E FWD

18.9

EV/EBITDA TTM

17.6

PEG

1.32

FCF yield TTM

5.6%

Growth

Revenue 3y

+5.8%/yr

Revenue YoY

+4.1%

Expected EPS

+46.7%

Quality

Piotroski F

4 / 9

ROIC

ALAN GLOBAL INTELLIGENCE · alanglobalintelligence.comquote as of 2026-07-28 06:38 UTC · fundamentals FY 2025 · SEC EDGAR

Verdict

Reading CHE’s filed statements…

Continue with CHE in ALAN

Full evidence trail, financial statements back a decade, valuation history, charts, and alerts.

Open in the workspace Create free account

For information and research only. Not investment advice. ALAN does not place trades or execute orders. Figures come from the sources shown and can lag the market; verify independently before making decisions. Past performance is not predictive of future results.